210 related articles for article (PubMed ID: 34074659)
21. International Treatment Recommendations Update: A Report from the GRAPPA 2016 Annual Meeting.
Coates LC; Chandran V; Ogdie A; O'Sullivan D; Brooke M; Steinkoenig I; Mease PJ; Ritchlin CT; Kavanaugh A
J Rheumatol; 2017 May; 44(5):684-685. PubMed ID: 28461525
[TBL] [Abstract][Full Text] [Related]
22. Benchmarking Care in Psoriatic Arthritis - The QUANTUM Report: A Report from the GRAPPA 2016 Annual Meeting.
Favier G; Gladman DD; Merola JF; Armstrong AW; Boehncke WH; Helliwell PS
J Rheumatol; 2017 May; 44(5):674-678. PubMed ID: 28461523
[TBL] [Abstract][Full Text] [Related]
23. Prologue: 2011 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Mease PJ; Gladman DD
J Rheumatol; 2012 Nov; 39(11):2181-3. PubMed ID: 23118282
[TBL] [Abstract][Full Text] [Related]
24. Tackling Patient Centricity: A Report from the GRAPPA 2016 Annual Meeting.
Goel N; O'Sullivan D; Steinkoenig I; James J; Lindsay CA; Coates LC; Latella J; Ogdie A; Chau J; Bertheussen H; Campbell W
J Rheumatol; 2017 May; 44(5):703-705. PubMed ID: 28461533
[TBL] [Abstract][Full Text] [Related]
25. Prologue: 2019 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Callis Duffin K; Gladman DD; Goel N; Gottlieb AB
J Rheumatol Suppl; 2020 Jun; 96():1-3. PubMed ID: 32482760
[TBL] [Abstract][Full Text] [Related]
26. GRAPPA Patient Research Partner Network: Update to the GRAPPA 2020 Annual Meeting.
O'Sullivan DP; Steinkoenig I
J Rheumatol Suppl; 2021 Jun; 97():64. PubMed ID: 34074671
[TBL] [Abstract][Full Text] [Related]
27. Prologue: 2015 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Boehncke WH; Gladman DD; Helliwell PS
J Rheumatol; 2016 May; 43(5):949-51. PubMed ID: 27134267
[TBL] [Abstract][Full Text] [Related]
28. Prologue: 2021 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Duffin KC; Gladman DD; Goel N; Gottlieb AB; FitzGerald O; McFarland LV
J Rheumatol; 2022 Jun; 49(6 Suppl 1):1-3. PubMed ID: 35169061
[TBL] [Abstract][Full Text] [Related]
29. Psoriasis and psoriatic arthritis educational initiatives: an update from the 2013 GRAPPA Annual Meeting.
Duffin KC; Garg A; Armstrong AW; Helliwell P; Mease PJ
J Rheumatol; 2014 Jun; 41(6):1240-3. PubMed ID: 24882862
[TBL] [Abstract][Full Text] [Related]
30. GRAPPA Trainees Symposium 2013: a report from the GRAPPA 2013 Annual Meeting.
Szentpetery A; Johnson MA; Ritchlin CT
J Rheumatol; 2014 Jun; 41(6):1200-5. PubMed ID: 24882852
[TBL] [Abstract][Full Text] [Related]
31. GRAPPA Trainees Symposium 2017: A Report from the GRAPPA 2017 Annual Meeting.
Furer V; Manasson J; Boehncke WH; Ritchlin CT
J Rheumatol Suppl; 2018 Jun; 94():4-10. PubMed ID: 29858346
[TBL] [Abstract][Full Text] [Related]
32. GRAPPA Trainees Symposium 2016: A Report from the GRAPPA 2016 Annual Meeting.
Polachek A; Stober CB; Gudbjornsson B; Ritchlin CT
J Rheumatol; 2017 May; 44(5):661-667. PubMed ID: 28461521
[TBL] [Abstract][Full Text] [Related]
33. Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative.
Perez-Chada LM; Cohen JM; Gottlieb AB; Duffin KC; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF
Arch Dermatol Res; 2018 Nov; 310(9):701-710. PubMed ID: 30167814
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps.
Tillett W; McHugh N; Orbai AM; Ogdie A; Leung YY; Coates LC; Mease PJ; Gladman DD; Brooke M; Packham J; O'Sullivan D; FitzGerald O; Helliwell PS
J Rheumatol Suppl; 2020 Jun; 96():11-18. PubMed ID: 32482762
[TBL] [Abstract][Full Text] [Related]
35. Outcome measures for psoriasis severity: a report from the GRAPPA 2012 annual meeting.
Callis Duffin K; Gottlieb AB
J Rheumatol; 2013 Aug; 40(8):1423-4. PubMed ID: 23908537
[TBL] [Abstract][Full Text] [Related]
36. GRAPPA 2018 Project Report.
Goel N; FitzGerald O; Gladman DD; Helliwell PS; Kavanaugh A; Maksymowych WP; Mease PJ; Ritchlin CT; Coates LC
J Rheumatol Suppl; 2019 Jun; 95():54-57. PubMed ID: 31154406
[TBL] [Abstract][Full Text] [Related]
37. International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual Meeting.
Kohn AH; Alavi A; Armstrong AW; Babalola F; Garg A; Gottlieb AB; Grilli L; Jemec GBE; Latella J; Marcus K; Merola JF; Ortega-Loayza AG; Siegel DM; Strand V; Tan JKL; Perez-Chada LM
Dermatology; 2022; 238(3):430-437. PubMed ID: 34537770
[TBL] [Abstract][Full Text] [Related]
38. Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group.
Leung YY; Tillett W; de Wit M; Orbai AM; Coates LC; FitzGerald O; Helliwell PS; Strand V; Mease PJ; Goel N; Christensen R; Merola JF; Lindsay CA; Ogdie A; Gossec L; Gladman DD
J Rheumatol; 2023 Nov; 50(Suppl 2):53-57. PubMed ID: 37419621
[TBL] [Abstract][Full Text] [Related]
39. GRAPPA Trainees Symposium 2015: A Report from the GRAPPA 2015 Annual Meeting.
Milliken M; Generali E; Marin J; Ritchlin CT
J Rheumatol; 2016 May; 43(5):952-8. PubMed ID: 27134268
[TBL] [Abstract][Full Text] [Related]
40. GRAPPA 2022 Patient Research Partners Network Update: Managing Growth.
Steinkoenig I; Goel N; Katz A
J Rheumatol; 2023 Nov; 50(Suppl 2):23-24. PubMed ID: 37419624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
